Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phalcis: Alimta + Cisplatin in Advanced Non-squamous NSCLC
NCT01088906Phase 2Terminated
- Sponsor
- Fundación GECP
- Start
- Jan 2010
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in non-small cell lung cancer (NSCLC), sponsored by Fundación GECP. Started Jan 2010; status: terminated.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01088906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01088906.